PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2018.01082019253234-244Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis CSeong Kyun Na, Byung-Cheol Songhttp://e-cmh.org/upload/pdf/cmh-2018-0108.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2018.0108, http://e-cmh.org/upload/pdf/cmh-2018-0108.pdf
Gastroenterology10.1016/s0016-5085(12)63713-520121425S-958Sa1060 Long-Term Assessment of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients With Sustained Viral Response to Antiviral TherapyChun-Hsiang Wang, Kuo-Kwen Changhttps://api.elsevier.com/content/article/PII:S0016508512637135?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508512637135?httpAccept=text/plain
Journal of Hepatology10.1016/s0168-8278(11)60410-8201154S164408 RISK FACTORS FOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPYK.-C. Chang, T.-H. Huhttps://api.elsevier.com/content/article/PII:S0168827811604108?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827811604108?httpAccept=text/plain
Gastroenterology10.1053/j.gastro.2017.03.018201715261578-1587American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C InfectionIra M. Jacobson, Joseph K. Lim, Michael W. Friedhttps://api.elsevier.com/content/article/PII:S001650851730327X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S001650851730327X?httpAccept=text/plain
Cancer10.1002/cncr.211012005103122654-2655Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapyMonica Basso, Francesco Torre, Antonino Picciottohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.21101, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.21101
Clinical Infectious Diseases10.1093/cid/ciz11422019Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet!Paul J Pockros, Jason J Panhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciz1142/32289780/ciz1142.pdf, http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciz1142/32289780/ciz1142.pdf
Journal of Viral Hepatitis10.1111/jvh.126652017246472-476Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitiH. Toyoda, T. Tada, K. Takaguchi, T. Senoh, N. Shimada, A. Hiraoka, K. Michitaka, T. Ishikawa, T. Kumadahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12665, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12665/fullpdf
Clinical Infectious Diseases10.1093/cid/ciz3592019Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic ResponseHidenori Toyoda, Toshifumi Tada, Satoshi Yasuda, Kazuyuki Mizuno, Takanori Ito, Takashi Kumadahttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciz359/28918910/ciz359.pdf
GastroHep10.1002/ygh2.418202025247-252Impact of COVID‐19 pandemic on surveillance of hepatocellular carcinoma: A study in patients with chronic hepatitis C after sustained virologic responseHidenori Toyoda, Satoshi Yasuda, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Shusuke Kitabatake, Satoshi Yamamoto, Shohei Shiota, Manabu Furoi, Takahiro Koyabu, Daiju Furukawa, Takashi Kumada, Yoshio Sumidahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fygh2.418, https://onlinelibrary.wiley.com/doi/pdf/10.1002/ygh2.418, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ygh2.418, https://onlinelibrary.wiley.com/doi/pdf/10.1002/ygh2.418
Gastroenterology10.1016/s0016-5085(19)40379-x20191566S-1344Tu1499 – Vitamin D Deficiency and Sustained Virologic Response on Antiviral Therapy with Pegylated Interferon Alpha 2 and Ribavirin in Patients with Chronic Hepatitis C, Genotype-1Elena Kukhareva, Olga Tarasova, Pavel Ogurtsovhttps://api.elsevier.com/content/article/PII:S001650851940379X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S001650851940379X?httpAccept=text/plain